age-related macular degeneration. Visual disturbances and blindness
Conditions
Interventions
Avastin 1 / 25mg at 0.05 liquid Injection? Second and third injections were repeated one month after the first injection..
Treatment - Drugs
Avastin 1 / 25mg at 0.05 liquid Injection? Second and third injections were repeated one month after the first injection.
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
65 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : age = 65 years, no history of previous treatment, angiographic evidence of leakage or macular thickness by OCT, new subretinal hemorrhage was associated with decreased visual acuity. exclusion criteria : history of glucoma treatment surgery , history of ocular inflammation , history of thrombo-embolic diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity. Timepoint: Baseline?One month after the intervention?three month after the intervention? six month after the intervention. Method of measurement: Snellen chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Myocardial infarction, stroke and venous thromboembolism, hemorrhage, inflammation of the eye, uveitis, endophthalmitis, glaucoma, retinal detachment, premature cataract. Timepoint: Baseline, one month after the intervention, three months after the intervention, six months after the intervention. Method of measurement: Doctor - EKG - slit lamp examination - an examination with the ophthalmoscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtaei kachoei abas
valiasr hospital
Outcome results
None listed